Subjective cognitive decline in cognitively normal elders from the community or from a memory clinic: Differential affective and imaging correlates |
| |
Authors: | Audrey Perrotin Renaud La Joie Vincent de La Sayette Louisa Barré Florence Mézenge Justine Mutlu Denis Guilloteau Stéphanie Egret Francis Eustache Gaël Chételat |
| |
Institution: | 1. INSERM, U1077, Caen, France;2. Université de Caen Normandie, UMR-S1077, Caen, France;3. Ecole Pratique des Hautes Etudes, UMR-S1077, Caen, France;4. CHU de Caen, U1077, Caen, France;5. CHU de Caen, Service de Neurologie, Caen, France;6. CEA, DRF/I2BM, LDM-TEP Group, Caen, France;7. CNRS, UMR ISTCT 6301, LDM-TEP Group, Caen, France;8. INSERM U930, Université François Rabelais de Tours, CHRU de Tours, Tours, France |
| |
Abstract: | IntroductionSubjective cognitive decline (SCD) could indicate preclinical Alzheimer's disease, but the existing literature is confounded by heterogeneous approaches to studying SCD. We assessed the differential cognitive, affective, and neuroimaging correlates of two aspects of SCD: reporting high cognitive difficulties on a self-rated questionnaire versus consulting at a memory clinic.MethodsWe compared 28 patients from a memory clinic with isolated SCD, 35 community-recruited elders with similarly high levels of self-reported cognitive difficulties, and 35 community-recruited controls with low self-reported cognitive difficulties.ResultsIncreased anxiety and amyloid β deposition were observed in both groups with high self-reported difficulties, whereas subclinical depression and (hippocampal) atrophy were specifically associated with medical help seeking. Cognitive tests showed no group differences.DiscussionThese results further validate the concept of SCD in both community- and clinic-based groups. Yet, recruitment methods influence associated biomarkers and affective symptomatology, highlighting the heterogeneous nature of SCD depending on study characteristics. |
| |
Keywords: | Alzheimer's disease Subjective cognitive decline Cognitive complaint Preclinical Amyloid β Florbetapir-PET MRI Atrophy Hippocampus Anxiety Depression |
本文献已被 ScienceDirect 等数据库收录! |
|